LCN2 and breast cancer: The involvement of lipocalin-2 in tumor genesis has particularly been studied in breast cancer, where lipocalin-2 (NGAL) expression is associated with poor prognosis in human primary breast cancer [31] and an increased urinary level of lipocalin-2 correlates with aggressiveness of the cancer [32].